Interleukin-2 as anticancer immunotherapy in the age of checkpoint inhibition

被引：1
|
作者：
Garbe, Claus [1 ]
机构：
[1] Eberhard Karls Univ Tubingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
D O I：
10.21037/tcr.2016.07.02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S313 / S314
页数：2
相关论文
共 50 条
  • [41] NEW APPROACHES TO THE IMMUNOTHERAPY OF CANCER USING INTERLEUKIN-2
    ROSENBERG, SA
    LOTZE, MT
    MULE, JJ
    ANNALS OF INTERNAL MEDICINE, 1988, 108 (06) : 853 - 864
  • [42] Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
    Wagner, Samuel C.
    Markosian, Boris
    Ajili, Naseem
    Dolan, Brandon R.
    Kim, Andy J.
    Alexandrescu, Doru T.
    Dasanu, Constantin A.
    Minev, Boris
    Koropatnick, James
    Marincola, Francesco M.
    Riordan, Neil H.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [43] Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
    Samuel C Wagner
    Boris Markosian
    Naseem Ajili
    Brandon R Dolan
    Andy J Kim
    Doru T Alexandrescu
    Constantin A Dasanu
    Boris Minev
    James Koropatnick
    Francesco M Marincola
    Neil H Riordan
    Journal of Translational Medicine, 12
  • [44] Interleukin-2 immunotherapy in auto-immune disorders
    Saadoun, D.
    Cacoub, P.
    REVUE DE MEDECINE INTERNE, 2013, 34 (03): : 133 - 135
  • [45] PERSPECTIVES ON INTERLEUKIN-2 IMMUNOTHERAPY FOR COLON-CANCER
    CHANG, AE
    GASTROENTEROLOGY, 1994, 107 (06) : 1890 - 1892
  • [46] Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
    Liao, Wei
    Lin, Jian-Xin
    Leonard, Warren J.
    IMMUNITY, 2013, 38 (01) : 13 - 25
  • [47] INHIBITION OF RELEASE OF INTERLEUKIN-2 BY VINCRISTINE AND VINBLASTINE
    AHMED, K
    HAMIED, TAA
    TURK, JL
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1987, 9 (04) : 391 - 407
  • [48] INHIBITION OF INTERLEUKIN-2 ACTIVITY BY NORMAL SERUM
    KLASSEN, LW
    AHMANN, GB
    BALLAS, ZK
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 563 - 563
  • [49] URINARY INTERLEUKIN-2 INHIBITION IN PATIENTS WITH CYSTITIS
    FLEISCHMANN, JD
    WENTWORTH, DB
    THOMAS, KM
    IMBEMBO, AL
    IMMUNOLOGICAL INVESTIGATIONS, 1989, 18 (06) : 825 - 831
  • [50] CANCER-IMMUNOTHERAPY USING INTERLEUKIN-2 AND INTERLEUKIN-2-ACTIVATED LYMPHOCYTES
    ROSENBERG, SA
    LOTZE, MT
    ANNUAL REVIEW OF IMMUNOLOGY, 1986, 4 : 681 - 709
12345